Sec Form 13G Filing - Tasso Partners, LLC filing for - 2025-11-12

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  Tasso Partners, LLC owns the DarioHealth Corp. (the "Issuer") shares; Tasso Capital, LLC is the manager which controls Tasso Partners, LLC and Dana Carrera controls Tasso Capital, LLC. (2) Consists of (i) 612,558 shares of common stock held by the Reporting Person, and (ii) pre-funded warrants exercisable into 1,113,078 shares of common stock, which contain a contractually stipulated 9.99% ownership restriction and which are beneficially owned by Dana Carrera, which is the trustee of GCL Family Trust (the "Trust"), and included pursuant to Rule 13d-3(d)(1)(i) of the Securities Exchange Act of 1934, as amended. (3) The percentage ownership was calculated based on a denominator which is the sum of 6,768,184 Common Stock outstanding as of the filing date of this report. All information included herein relating to shares or price per share reflects the 1-for-20 reverse split effected by the Issuer on August 28, 2025.


SCHEDULE 13G



Comment for Type of Reporting Person:  Tasso Partners, LLC owns the DarioHealth Corp. (the "Issuer") shares; Tasso Capital, LLC is the manager which controls Tasso Partners, LLC and Dana Carrera controls Tasso Capital, LLC. (2) Shared voting and dispositive power consists of (i) 612,558 shares of Common Stock held by the Reporting Person, and (ii) pre-funded warrants exercisable into 1,113,087 shares of common stock which contain a contractually stipulated 9.99% ownership restriction and, which are beneficially owned by Dana Carrera, which is the trustee of the Trust, and included pursuant to Rule 13d-3(d)(1)(i) of the Securities Exchange Act of 1934, as amended. (3) Sole voting and dispositive power consists of 6,250 shares of Common Stock owned by the Trust, which are beneficially owned by Dana Carrera, the trustee of the Trust. (4) Aggregate amount beneficially owned consists of (i) 612,558 shares of Common Stock held by the Reporting Person, and (iii) pre-funded warrants exercisable into 1,113,087 shares of common stock which contain a contractually stipulated 9.99% ownership restriction and, which are beneficially owned by Dana Carrera, the trustee of the Trust, and included pursuant to Rule 13d-3(d)(1)(i) of the Securities Exchange Act of 1934, as amended. (5) The percentage ownership was calculated based on a denominator which is the sum of 6,768,184 Common Stock outstanding as of the filing date of this report. All information included herein relating to shares or price per share reflects the 1-for-20 reverse split effected by the Issuer on August 28, 2025.


SCHEDULE 13G


 
Tasso Partners, LLC
 
Signature:/s/ Dana Carrera
Name/Title:Dana Carrera/Manager of Tasso Capital, LLC, which controls Tasso Partners, LLC
Date:11/12/2025
 
Dana Carrera
 
Signature:/s/ Dana Carrera
Name/Title:Dana Carrera
Date:11/12/2025
primary_doc.xml